Ke Li is a research assistant at the West China Hospital of Stomatology, Sichuan University. His research focuses on oral oncology, particularly the histone lactylation-mediated regulation of OLR1 in oral squamous cell carcinoma and its role in drug resistance. He has also led systematic and evidence-based studies on near-infrared imaging for surgical margin assessment in head and neck tumor resection, as well as on the pharmacogenetics of medication-related osteonecrosis of the jaw. These studies have resulted in publications in Quantitative Imaging in Medicine and Surgery and Science China: Life Sciences, along with a co-invented patent for a minimally invasive soft tissue retractor. Ke's expertise spans molecular and cellular biology techniques, immunohistochemistry, and advanced data analysis, with a strong interest in translational oncology and precision medicine.